Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

Medicum Group acquires Fertilitas, becomes Estonia’s largest private health fund partner

Medicum Group, an Estonia-based provider of general and specialised medical services backed by pan-Baltic private equity firm Livonia Partners, has acquired AS Fertilitas, a provider of otorhinolaryngology, gynaecology, and surgical care. The combined entity is set to become the largest private contractual partner of the Estonian Health Insurance Fund in specialised medical care, offering diagnostic and treatment services across 18 medical specialties.
April 9, 2026

HBI 2026: Building the future of femtech through data and AI

The HBI 2026 included a session on femtech featuring Rhiannon White, CEO of Clue; Mario Aichlseder, Founder and CEO of Hello Inside; and Samuel Levy, Founding Partner at Lauxera Capital Partners. The discussion looked at how femtech is evolving, what makes up a “femtech stack”, and where the biggest opportunities lie in consumer-driven women’s health. If you think of a stack as the different layers that create value, in this space that can include reproductive data, metabolic insights, AI, behaviour change, clinical validation, and more. The panel explored how companies and investors are approaching these layers, and which ones are actually scalable and worth investing in.
April 2, 2026

HBI 2026: Next-generation partnerships driving healthcare transformation

Healthcare is at a turning point, driven by rising patient expectations, rapid technological progress, and increasing pressure to deliver value-based care. At HBI 2026, a panel featuring Alexander Klos (CFO, Beyond Imaging), Charles Niehaus (Executive Director, Affidea), Ranjan Singh (CEO and Co-Founder, HealthHero), and François Clérin (Managing Director, Enterprise Solutions, GE Healthcare) discussed how partnerships, digital innovation, and patient-centred models are reshaping delivery.
April 2, 2026

LDC exits PAM Healthcare for £100 million

Private equity investment firm LDC has completed the exit of occupational health services provider PAM Healthcare to the UK’s largest pure play occupational health provider by revenue, Optima Health, for £100 million.
April 2, 2026

Hygie31 acquires CentralFarma, establishes Spain subsidiary

Hygie31 group, a pan-European healthcare and wellness platform, has acquired Spanish pharmacy group CentralFarma, establishing its international subsidiary in Spain, Hygie31 España. CentralFarma currently owns 230 pharmacies, mainly in Andalusia, with a turnover of close to €330 million.
April 2, 2026

HBI 2026: Why now is the time to invest in DACH

Across Europe, the DACH region stands out for its scale, stability, and potential for consolidation.  At HBI 2026, a panel of senior investors and operators highlighted why the region is increasingly seen as an attractive and underappreciated market for healthcare consolidation.
April 1, 2026

Healthcare Holding Schweiz buys stake in Alpin Orthodontics

Healthcare Holding Schweiz, a medtech and services firm backed by private equity firm KKA Partners and family office Winterberg Advisory, has acquired shares in Swiss orthodontic products and consumables provider Alpin Orthodontics AG. Founded in 1995, Alpin is the exclusive representative in Switzerland and Liechtenstein for several major international brands, including GC Orthodontics and Tiger […]
March 19, 2026

SHS Capital exits and reinvests in German speciality pharma AMW GmbH

Healthcare focused private equity firm SHS Capital has exited and reinvested in German speciality pharma company AMW GmbH, as part of a syndicate of investors including specialist investment firm Ren Life Sciences and global investment firm Juno Capital Partners.
March 19, 2026

EQT fully exits dermatology company Galderma

Swedish private equity firm EQT has fully exited Swiss pure-play dermatology company Galderma through a CHF 4.9 billion (~$6.21 billion) block trade. EQT and its co-investors, including sovereign wealth funds Abu Dhabi Investment Authority (ADIA) and GIC (Singapore), sold their remaining 14.3% stake (around 34 million shares). EQT VIII is expected to receive approximately CHF 1.3 billion (~$1.65 billion).
March 18, 2026

Schön Klinik Group to exit the UK 

Schoen Klinik Group, Germany’s fourth-largest family-run hospital, is exiting the UK market, following a portfolio reconsideration. With this exit, Schoen Klinik will now focus primarily on its core market, Germany. 
March 18, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us